Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Willerson

Showing results (661-670 of 797) with videos related to

Pageof 80
Sort By:
Texas Heart Institute Journal|January 14, 2010
Obesity: an independent predictor of in-hospital postoperative renal insufficiency among patients undergoing cardiac surgery?Salim S Virani, Vijay Nambi, Vei-Vei Lee, et al.
Human Pathology|January 7, 2003
Matrix metalloproteinases and their tissue inhibitors in the lesions of cardiac and pulmonary sarcoidosis: an immunohistochemical studyA Adrián González, Ana M Segura, Koji Horiba, et al.
Cardiovascular Research|July 1, 1977
Infarct sizing with technetium-99m stannous pyrophosphate scintigraphy in dogs and man; relationship between scintigraphic and praecordial mapping estimates of infarct size in patientsJ T Willerson, R W Parkey, E M Stokely, et al.
Journal of the American College of Cardiology|December 1, 1995
One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarctionH V Anderson, C P Cannon, P H Stone, et al.
Circulation Research|November 1, 1986
Inhibition of cyclic flow variations in stenosed canine coronary arteries by thromboxane A2/prostaglandin H2 receptor antagonistsJ H Ashton, J M Schmitz, W B Campbell, et al.
Circulation|December 1, 1977
Clinicopathologic study of persistently positive technetium-99m stannous pyrophosphate myocardial scintigrams and myocytolytic degeneration after myocardial infarctionL M Buja, L R Poliner, R W Parkey, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 19, 2009
Combined therapy with simvastatin and bone marrow-derived mesenchymal stem cells increases benefits in infarcted swine heartsYue-Jin Yang, Hai-Yan Qian, Ji Huang, et al.
Contrast Media & Molecular Imaging|July 9, 2019
Labeling Stem Cells with a New Hybrid Bismuth/Carbon Nanotube Contrast Agent for X-Ray ImagingMayra Hernández-Rivera, Stephen Y Cho, Sakineh E Moghaddam, et al.
Revista Espanola De Cardiologia|June 24, 2008
[Diabetic and nondiabetic patients respond differently to transendocardial injection of bone marrow mononuclear cells: findings from prospective clinical trials in "no-option" patients]Pilar Jiménez-Quevedo, Guillherme V Silva, Ricardo Sanz-Ruiz, et al.
Nuclear Medicine and Biology|August 1, 1995
Biodistribution and radioimmunopharmacokinetics of 131I-Ama monoclonal antibody in atherosclerotic rabbitsM Chakrabarti, K T Cheng, K M Spicer, et al.
Pageof 80

Showing results (661-670 of 797) with videos related to

Sort By:
Pageof 80
Texas Heart Institute Journal|January 14, 2010
Obesity: an independent predictor of in-hospital postoperative renal insufficiency among patients undergoing cardiac surgery?Salim S Virani, Vijay Nambi, Vei-Vei Lee, et al.
Human Pathology|January 7, 2003
Matrix metalloproteinases and their tissue inhibitors in the lesions of cardiac and pulmonary sarcoidosis: an immunohistochemical studyA Adrián González, Ana M Segura, Koji Horiba, et al.
Cardiovascular Research|July 1, 1977
Infarct sizing with technetium-99m stannous pyrophosphate scintigraphy in dogs and man; relationship between scintigraphic and praecordial mapping estimates of infarct size in patientsJ T Willerson, R W Parkey, E M Stokely, et al.
Journal of the American College of Cardiology|December 1, 1995
One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarctionH V Anderson, C P Cannon, P H Stone, et al.
Circulation Research|November 1, 1986
Inhibition of cyclic flow variations in stenosed canine coronary arteries by thromboxane A2/prostaglandin H2 receptor antagonistsJ H Ashton, J M Schmitz, W B Campbell, et al.
Circulation|December 1, 1977
Clinicopathologic study of persistently positive technetium-99m stannous pyrophosphate myocardial scintigrams and myocytolytic degeneration after myocardial infarctionL M Buja, L R Poliner, R W Parkey, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 19, 2009
Combined therapy with simvastatin and bone marrow-derived mesenchymal stem cells increases benefits in infarcted swine heartsYue-Jin Yang, Hai-Yan Qian, Ji Huang, et al.
Contrast Media & Molecular Imaging|July 9, 2019
Labeling Stem Cells with a New Hybrid Bismuth/Carbon Nanotube Contrast Agent for X-Ray ImagingMayra Hernández-Rivera, Stephen Y Cho, Sakineh E Moghaddam, et al.
Revista Espanola De Cardiologia|June 24, 2008
[Diabetic and nondiabetic patients respond differently to transendocardial injection of bone marrow mononuclear cells: findings from prospective clinical trials in "no-option" patients]Pilar Jiménez-Quevedo, Guillherme V Silva, Ricardo Sanz-Ruiz, et al.
Nuclear Medicine and Biology|August 1, 1995
Biodistribution and radioimmunopharmacokinetics of 131I-Ama monoclonal antibody in atherosclerotic rabbitsM Chakrabarti, K T Cheng, K M Spicer, et al.
Pageof 80